Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthequity (HQY) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Healthequity (HQY) over the last 13 years, with Q4 2025 value amounting to $20.5 million.

  • Healthequity's Share-based Compensation fell 275.06% to $20.5 million in Q4 2025 from the same period last year, while for Oct 2025 it was $75.7 million, marking a year-over-year decrease of 1770.39%. This contributed to the annual value of $96.4 million for FY2025, which is 2498.22% up from last year.
  • Healthequity's Share-based Compensation amounted to $20.5 million in Q4 2025, which was down 275.06% from $19.1 million recorded in Q3 2025.
  • Over the past 5 years, Healthequity's Share-based Compensation peaked at $32.0 million during Q2 2024, and registered a low of $11.0 million during Q1 2022.
  • Its 5-year average for Share-based Compensation is $17.8 million, with a median of $18.2 million in 2022.
  • Per our database at Business Quant, Healthequity's Share-based Compensation surged by 7589.54% in 2024 and then plummeted by 5522.8% in 2025.
  • Over the past 5 years, Healthequity's Share-based Compensation (Quarter) stood at $13.3 million in 2021, then soared by 36.78% to $18.2 million in 2022, then grew by 19.22% to $21.7 million in 2023, then fell by 2.49% to $21.1 million in 2024, then decreased by 2.75% to $20.5 million in 2025.
  • Its Share-based Compensation was $20.5 million in Q4 2025, compared to $19.1 million in Q3 2025 and $14.3 million in Q2 2025.